Alkermes plc Reports Second Quarter 2026 Financial Results July 28, 2026 Alkermes plc (Nasdaq: ALKS) today reported financial results for the quarter ended June 30, 2026. To view the detailed second quarter 2026 earnings press release and presentation, please visit the company’s investor relations website at https://investor.alkermes.com. Alkermes will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) today, to discuss [...]
Algoma Central Corporation to Issue Second Quarter Financial Results on August 7, 2026 July 24, 2026 Algoma Central Corporation (TSX: ALC) today announced it will report its financial results for the three and six months ended June 30, 2026 before market open on August 7, 2026. The Company’s second quarter earnings release and full financial results will be available on the Company’s website and on SEDAR. Algoma Central Corporation is a [...]
Almirall H1 2026 Results July 24, 2026 Almirall delivers solid H1 2026 results growing Net Sales by 7.5% and EBITDA by 23.7%, driven by its strong European Dermatology business – reiterating guidance aligned with long-term growth trajectory Net Sales increased by 7.5% YoY to €602.7 MM, while EBITDA grew by 23.7% to €150.7 MM, reflecting strong commercial and operational execution. The European Dermatology business continues to drive growth, increasing 18.1% YoY to €341.9 MM, supported by strong performance of its key growth drivers and favourable underlying market growth. Continued solid performance of the biologics portfolio, with Ilumetri® delivering 10.5% increase to €125.2 MM and Ebglyss® growing 88.2% to €84.5 MM in Net Sales, supported by sustained growth in recent launch markets. The broader dermatology portfolio delivers positive performance, including Wynzora® (19.3%, total of €20.4 MM) and Klisyri® (13.9%, total of €15.6 MM). Almirall advances its innovation strategy through progress across its R&D pipeline, including four ongoing PoC/Phase II studies and two additional PoC studies planned to be initiated by end of 2026, targeting five dermatological diseases. The first readouts are expected towards the end of 2026. Almirall signs a strategic research collaboration and licensing agreement with Certest Biotec to discover and develop novel treatments for rare dermatologic diseases and recurrent cutaneous conditions. Reiterated guidance for the full year 2026: 9-12% growth and € 270MM to € 290MM EBITDA.
Allegion (NYSE: ALLE) Reports Q2-2026 Financial Results July 23, 2026 Low-Double Digit Revenue Growth, High-Teens EPS Growth; Raising Full-Year 2026 Outlook Quarterly Financial Highlights (All comparisons are year-over-year, unless otherwise noted) Net earnings per share (EPS) of $2.15, up 16.2% compared with $1.85; Adjusted EPS of $2.40, up 17.6% compared with $2.04 Revenues of $1,151.5 million, up 12.7% on a reported basis and up 6.9% on an organic basis Operating margin of 22.1%, compared with 21.5%; Adjusted operating margin of 24.2%, compared with 23.7%
Luxfer Announces Date of Second Quarter 2026 Earnings Conference Call July 22, 2026 Luxfer Holdings PLC (NYSE: LXFR) (“Luxfer” or the “Company”), a global industrial company innovating niche applications in materials engineering, today announced the details for its second quarter 2026 earnings conference call. Date and time: Wednesday July 29, 2026, at 8:30 a.m. Eastern Time Luxfer participants: Andy Butcher Chief Executive Officer Steve Webster Chief Financial [...]
Smurfit Westrock to Announce 2026 Second Quarter Results on July 29, 2026 July 15, 2026 Smurfit Westrock plc (NYSE:SW) plans to release its financial results for the second quarter ended June 30, 2026 on Wednesday, July 29, 2026 at 6.30 am ET (11.30 am BST). Smurfit Westrock’s earnings release and related materials will be available at smurfitwestrock.com. At 7.30 am ET (12.30 pm BST) on the same day, Smurfit Westrock’s [...]
Alkermes to Report Second Quarter Financial Results on July 28, 2026 July 14, 2026 Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) on Tuesday, July 28, 2026 to discuss the company’s second quarter financial results. The webcast player and accompanying slides may be accessed on the Investors section of Alkermes’ website at www.alkermes.com. The conference call may be [...]
IFF to Release Second Quarter 2026 Results on August 4, 2026 July 9, 2026 IFF (NYSE: IFF) today announced that it will release its second quarter 2026 earnings results following the market close on Tuesday, August 4, 2026. The management team will host a live webcast on Wednesday, August 5, 2026, at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live [...]
Arm Announces Earnings Release Date for First Quarter Fiscal Year Ended 2027 July 8, 2026 Arm Holdings plc (NASDAQ: ARM) will report financial results for the first quarter of fiscal year 2027 on Wednesday, July 29, 2026, after market close. The company will host a conference call via audio webcast at 14:00 Pacific Time (17:00 Eastern Time / 22:00 British Summer Time) to review its financial results and business outlook. [...]
IGI to Release Second Quarter and Half Year 2026 Financial Results on August 4, 2026 July 7, 2026 International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that it expects to release financial results for the second quarter and first half of 2026 on Tuesday, August 4, 2026, after the close of the U.S. financial markets. The results, along with an accompanying slide presentation, will be posted in the [...]